Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats

被引:37
|
作者
Boesen, Erika I. [1 ]
Williams, Douglas L. [1 ]
Pollock, Jennifer S. [1 ]
Pollock, David M. [1 ]
机构
[1] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA
基金
美国国家卫生研究院;
关键词
hypertension; kidney; macrophage; mineralocorticoid; T-lymphocyte; IMMUNE CELL INFILTRATION; ANGIOTENSIN-II; SENSITIVE HYPERTENSION; BLOOD-PRESSURE; RENAL DAMAGE; MINERALOCORTICOID RECEPTORS; ARTERIAL-PRESSURE; OXIDATIVE STRESS; T-CELL; KIDNEY;
D O I
10.1111/j.1440-1681.2010.05428.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P>1. The interplay between the immune and renin-angiotensin systems is emerging as a crucial factor in the development and progression of hypertension. The aim of the present study was to determine the involvement of immune cells in the hypertension and renal injury produced by a non-angiotensin II-dependent form of hypertension, namely deoxycorticosterone acetate (DOCA)-salt-induced hypertension, in rats. 2. Male Sprague-Dawley rats underwent uninephrectomy and received either a sustained-release pellet of DOCA s.c. and 0.9% NaCl (saline) to drink for 21 days or a placebo pellet and water to drink for 21 days. Additional groups of DOCA-salt- and placebo-treated rats were treated concurrently with the immune suppressant mycophenolate mofetil (MMF; 30 mg/kg per day). Rats were placed in metabolic cages for 24 h urine collection prior to and at weekly intervals during the 21 day experimental period. 3. Mycophenolate mofetil significantly attenuated the development of hypertension in DOCA-salt rats compared with untreated DOCA-salt hypertensive rats (mean arterial pressure by telemetry on Day 18 146 +/- 7 vs 180 +/- 3 mmHg, respectively; P < 0.001), as well as proteinuria (87 +/- 27 vs 305 +/- 63 mg/day, respectively, on Day 21) and albuminuria (51 +/- 15 vs 247 +/- 73 mg/day, respectively, on Day 21). Creatinine clearance was better preserved in MMF-treated DOCA-salt rats compared with untreated DOCA-salt rats (0.74 +/- 0.07 vs 0.49 +/- 0.09 mL/min, respectively; P < 0.05), but was still significantly reduced compared with that in the placebo group (1.15 +/- 0.12 mL/min; P < 0.05). Finally, MMF treatment significantly attenuated the DOCA-salt-induced rise in renal cortical T-lymphocyte and macrophage infiltration (P < 0.05). 4. These data indicate that immune cells play a deleterious role in both the hypertension and renal injury associated with DOCA-salt hypertension.
引用
收藏
页码:1016 / 1022
页数:7
相关论文
共 50 条
  • [1] Ginkgo biloba extract attenuates the development of hypertension in deoxycorticosterone acetate-salt hypertensive rats
    Umegaki, K
    Shinozuka, K
    Watarai, K
    Takenaka, H
    Yoshimura, M
    Daohua, P
    Esashi, T
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2000, 27 (04) : 277 - 282
  • [2] 5-CARBOXAMIDOTRYPTAMINE ATTENUATES THE DEVELOPMENT OF DEOXYCORTICOSTERONE ACETATE-SALT HYPERTENSION IN RATS
    BALASUBRAMANIAM, G
    LEE, HS
    MAH, SC
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 276 (1-2) : 183 - 190
  • [3] Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats
    Jadhav, Ashok
    Torlakovic, Emina
    Ndisang, Joseph Fomusi
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2009, 296 (03) : F521 - F534
  • [4] Renal impairment in deoxycorticosterone acetate-salt hypertensive rats
    Dallemagne, C
    Ooi, SY
    Brown, L
    Gobé, G
    Endre, Z
    NEPHROLOGY, 2000, 5 (04) : 277 - 284
  • [5] Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats
    Dobrzynski, E
    Wang, C
    Chao, J
    Chao, L
    HYPERTENSION, 2000, 36 (06) : 995 - 1001
  • [6] Effect of pravastatin on nephroprotection in deoxycorticosterone acetate-salt hypertensive rats
    Kang, Chih-Sen
    Chang, Nen-Chung
    Chang, Shen-Tien
    Lin, Chih-Chan
    Lee, Tsung-Ming
    JOURNAL OF HYPERTENSION, 2009, 27 (11) : 2232 - 2243
  • [7] CEREBRAL VASCULAR RESPONSIVENESS IN DEOXYCORTICOSTERONE ACETATE-SALT HYPERTENSIVE RATS
    SOLTIS, EE
    BOHR, DF
    AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (01): : H198 - H203
  • [8] Microvascular responses to endothelin in deoxycorticosterone acetate-salt hypertensive rats
    Zhao, HL
    Joshua, IG
    Porter, JP
    AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (07) : 819 - 826
  • [9] Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats
    Lee, Tsung-Ming
    Chen, Chien-Chang
    Chang, Nen-Chung
    CLINICAL SCIENCE, 2012, 123 (7-8) : 445 - 457
  • [10] Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats
    Brown, L
    Ooi, SY
    Lau, K
    Sernia, C
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2000, 27 (04) : 263 - 269